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Abstract  
Erythema ab igne is a localised, cutaneous condition consisting of reticulate hyperpigmentation, epidermal 
atrophy, and telangiectasias. It is caused by repetitive and prolonged exposure to moderate heat that is 
insufficient for producing burns. Currently, erythema ab igne is most commonly observed following repeated use 
of hot water bottles, infrared lamps and heating pads. If not properly treated, erythema ab igne can become 
chronic and even malignant. We report a case of erythema ab igne, successfully treated with systemic 
mesoglycan-based therapy, and local therapy with bioflavonoids. 
 
 
Introduction 
 
“Erythema ab igne” (EAI) or “erythema 
caloric” is a dermatosis supported by a reactive 
vascular impairment that develops after repeated and 
long-term exposure to heat [1]. The intensity of the 
infrared radiation responsible for this event is not 
sufficient for producing burns. 
Erythema ab igne is a reticular, pigmented 
and telangiectatic dermatosis. Typically the lesions 
are localised in skin areas directly exposed to the heat 
source. 
Although rare, a bullous form of erythema ab 
igne has been described, characterised by bullae and 
crusts within a localised area of reticular, brown and 
macular pigmentation [2]. Erythema ab igne is usually 
asymptomatic, but patients may report a burning 
sensation and pruritus. 
The histopathological alterations [4] include 
epidermal atrophy, hyperkeratosis and parakeratosis, 
and aspects of lichenification. The dermis shows 
abundant melanophages and occasional elastic fibre 
alterations similar to actinic elastosis. There is also 
melanin and hemosiderin deposition and formation of 
telangiectasis, together with perivascular infiltration of 
polymorphonuclear cells. 
Erythema ab igne is usually a chronic 
disease. The most significant long term risk is the 
malignant transformation of erythema ab igne into 
cutaneous squamous cell carcinomas or Merkel cell 
carcinomas [5-6]. 
The diagnosis is mainly clinical and supported 
by a medical history. On rare occasions, histology 
may be necessary. 
At present, there are no effective medical 
therapies available. 
The paramount goal of therapy is to eliminate 
the cause. According to some studies, treatment with 
topical 5-fluorouracil [8] or imiquimod may be useful in 
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reducing or eliminating dysplasia of the keratinocytes. 
A case report describes the successful of 
photodynamic therapy [9]. 
 
 
Case report 
 
An otherwise healthy, 25-year-old female 
subject affected by erythema ab igne (Fig. 1), came to 
our Clinic with a brown reticular lesion on her legs. 
 
Figure 1: Woman, 25 years old, affected by erythema ab igne 
 
 
The dermatosis, similar to reticular livedo, 
was lightly pigmented, asymptomatic, and did not 
change significantly with digital pressure. Otherwise, 
the patient did not report any subjective symptoms 
and enjoyed apparent good health. 
 
Figure 2: The lesions observed with a digital zoom 
 
 
The lesions had a peculiar distribution as they 
were limited to the proximal right side of both legs. We 
studied her anamnestic history in order to understand 
her habits and lifestyle and clarify the nature of the 
lesions. 
 
Figure 3: The lesions observed with a digital zoom 
 
 
She told us she was a doughnut cook in a 
kiosk on the city streets. To keep warm in winter, she 
used a small electric heater on the floor on the right-
hand side of the kiosk. After about two months of 
exposure to the heater, she noticed a brown, reticular 
dermatosis on her legs which had become 
increasingly darker over time. This helped us correlate 
the lesions with the heat source as they were visible 
on the right side of both legs, in the skin region 
directly exposed to the heater. A physical examination 
did not reveal any clinical signs of abnormal collagen. 
Routine blood tests for were negative for autoimmune 
diseases (ANA and antiphospholipid antibodies), 
diabetes, viral hepatitis or any other systemic 
diseases. 
 
 
Figure 4: The patient after the treatment 
 
We advised the patient to stop using the 
heater and prescribed oral mesoglycan 50 mg twice 
daily and a topical gel (glycosaminoglycan, flavonoids, 
antioxidants, saponins, etc.) with a vascular action to 
be applied twice daily. 
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Figure 5: The patient after the treatment 
 
At the one-month follow-up there was a partial 
regression of the lesion, so we reduced the dosage of 
mesoglycan to 50 mg/day for two months. 
At the end of this period the lesions had 
completely healed (Fig. 4-5). 
 
 
Discussion 
 
Erythema ab igne (EAI), also known as 
“toasted skin syndrome” and “fire stains”, is a 
localised, cutaneous condition, consisting of reticulate 
hyperpigmentation, dusky erythema, epidermal 
atrophy, and telangiectasias. 
Historically, it was often seen on the inner 
thighs and legs of women who sat in front of a stove 
or open fire. Nowadays erythema ab igne is a rare 
disease due to the general availability of central 
heating. 
However, cases of erythema ab igne are still 
reported, although less frequently. 
Occupational exposure to heat (such as 
bakers, blacksmiths, foundry workers, etc.) [10] may 
cause erythema ab igne. More rarely, the skin 
disorder has also been described on the legs of 
people exposed to a car heater for long periods. 
In less privileged social classes we continue 
to observe cases deriving from repeated use of 
heaters, electric blankets or heated cushions. 
Even exposure to infrared lamps may cause 
erythema ab igne, often characterised by the 
simultaneous damage to ocular structures (e.g. 
cataracts). 
Some patients develop erythema ab igne 
using a heat source (e.g. heating pad, heated blanket 
or hot water bottle
 
[11]) to relieve chronic pain. This 
typically occurs in patients with chronic pancreatitis 
[12-13] or cancer. Erythema ab igne has also been 
described following the use of sauna belts for 
abdominal obesity, and in patients using heated 
recliners to relieve chronic lower back pain. 
One case report describes erythema ab igne 
following the use of a heating/cooling blanket in the 
intensive care unit [14]. 
Moreover, erythema ab igne could be 
associated with numerous physiotherapeutic 
treatments [7], which uses ultrasound and short wave 
diathermy to promote a rapid tissue vibration in order 
to generate heat and provide pain relief. 
Finally, there is the “laptop dermatitis” [15-17]. 
Some laptops may generate significant heat when 
placed on the legs for long periods resulting in 
erythema ab igne. 
The main pathogenetic aspects seem to be 
represented by a degeneration of the elastic fibres, by 
the degeneration of basal cells with release of melanin 
pigment, and by vascular changes. Confirming this is 
the higher incidence of this disease in patients with 
predisposing lesions, such as acrocyanosis, 
acrorigosis, and telangiectasias, etc. 
The first sign is a transient macular erythema 
in a broad, reticulated pattern that blanches easily. At 
this stage, Erythema ab igne is very similar to reticular 
livedo but not limited to digital pressure or heat. 
Furthermore, erythema ab igne lesions are more 
circumscribed than livedo reticularis and have a 
precise local history. 
With prolonged and repeated exposure, areas 
of reticular erythema persist and become livid and 
hyperpigmented. Epidermal atrophy may overlie the 
reticulated pigmentation. Typically, the lesions are 
localized in skin areas directly exposed to the heat 
source. 
Although rare, a bullous form of erythema ab 
igne has also been described [3]. 
The histopathological alterations include 
epidermal atrophy, hyperkeratosis and parakeratosis, 
collagen fragmentation, melanin and hemosiderin 
deposition, the formation of telangiectasias, with 
perivascular infiltration of polymorphonuclear cells. 
The dermis shows abundant melanophages and 
occasional elastic fiber alterations similar to actinic 
elastosis (“thermal keratosis”). 
If not properly treated, Erythema ab igne has 
an insidious course and tends to become chronic. 
It also represents a precancerous lesion, 
which may evolve into squamous cell carcinomas [7] 
or Merkel cell carcinomas. 
Is very important to make a correct and early 
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diagnosis of this dermatosis and promptly implement 
appropriate treatment. Unfortunately, at present, there 
are no effective medical therapies available. 
Treatment with topical fluorouracil or 
imiquimod may be useful in reducing or eliminating 
keratinocyte dysplasia [8]. 
 In conclusion, the Authors report a case of 
erythema ab igne, in which they achieved healing of 
the lesions via removal of the patient from the heat 
source and early drug therapy. Oral mesoglycan is an 
antithrombotic and pro-fibrinolytic drug, which has 
been shown to be effective in the treatment of 
different vascular disorders, such as atherosclerosis, 
venous thrombosis, inflammatory vasculitis and 
others. Flavonoids are a class of plant metabolites, 
with important antioxidant and antiinflammatory 
properties. 
The anticoagulant action of oral mesoglycan 
and the vascular action of local flavonoids reduced the 
inflammation and luminal obliteration processes, 
which are the basis of erythema ab igne. 
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